Autoimmune Disease

Category

Spanish Pediatric Anti-MOG Study Group Discovery Could Accelerate Diagnosis & Treatment of Children with Life-Threatening Neurological Diseases

In observational research, a multi-center team of investigators called the “Spanish Pediatric Anti-MOG Study Group” discovered that 85% of children in a study with life-threatening autoimmune conditions had complete or near complete recovery after a specific biomarker...

Orchard Therapeutics Granted FDA Orphan Drug Designation for OTL-102 for X-linked Chronic Granulomatous Disease (X-CGD)

Orchard Therapeutics announced the U.S. FDA has granted Orphan Drug Designation for OTL-102, the company’s ex vivo autologous hematopoietic stem cell (HSC) gene therapy being investigated for the treatment of X-linked chronic granulomatous disease (X-CGD). The FDA may...

Immune Tolerance Network Launches Cell Therapy vs. Standard of Care Clinical Trial for Multiple Sclerosis Patients

The Immune Tolerance Network (ITN) has opened the BEAT-MS clinical trial for patient enrollment. BEAT-MS or “Best Available Therapy vs. Autologous Hematopoietic Stem Cell Transplant (AHSCT) for MS” will investigate high dose immunosuppression followed by AHSCT—a type...

Pin It on Pinterest